3.23.1 html 109 271 1 false 40 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 100050 - Statement - Consolidated Statements of Cash Flows Sheet http://landosbiopharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100060 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) Sheet http://landosbiopharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) Statements 6 false false R7.htm 100080 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies Organization and Summary of Significant Accounting Policies Notes 7 false false R8.htm 100090 - Disclosure - Fair Value Measurement Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurement Fair Value Measurement Notes 8 false false R9.htm 100100 - Disclosure - Consolidated Balance Sheet Components Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents Consolidated Balance Sheet Components Notes 9 false false R10.htm 100110 - Disclosure - Convertible Preferred Stock and Stockholders Equity (Deficit) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityDeficit Convertible Preferred Stock and Stockholders Equity (Deficit) Notes 10 false false R11.htm 100120 - Disclosure - Stock-based compensation Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensation1 Stock-based compensation Notes 11 false false R12.htm 100130 - Disclosure - Commitments and Contingencies Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 100140 - Disclosure - License Agreement Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureLicenseAgreement1 License Agreement Notes 13 false false R14.htm 100150 - Disclosure - Income Taxes Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxes1 Income Taxes Notes 14 false false R15.htm 100180 - Disclosure - Subsequent Events Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 15 false false R16.htm 100190 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://landosbiopharma.com/20221231/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies 16 false false R17.htm 100200 - Disclosure - Organization and Summary Of Significant Accounting Policies (Tables) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables Organization and Summary Of Significant Accounting Policies (Tables) Tables 17 false false R18.htm 100210 - Disclosure - Fair Value Measurement (Tables) Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementTables Fair Value Measurement (Tables) Tables http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurement 18 false false R19.htm 100220 - Disclosure - Consolidated Balance Sheet Components (Tables) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables Consolidated Balance Sheet Components (Tables) Tables http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents 19 false false R20.htm 100230 - Disclosure - Stock-based compensation (Tables) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensationTables Stock-based compensation (Tables) Tables http://landosbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensation1 20 false false R21.htm 100240 - Disclosure - Income Taxes (Tables) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://landosbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxes1 21 false false R22.htm 100270 - Disclosure - Net Loss Per Common Share (Tables) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureNetLossPerCommonShareTables Net Loss Per Common Share (Tables) Tables 22 false false R23.htm 100280 - Disclosure - Organization and Description of the Business - Additional Information (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails Organization and Description of the Business - Additional Information (Details) Details 23 false false R24.htm 100290 - Disclosure - Organisation and Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureOrganisationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Organisation and Summary of Significant Accounting Policies - Additional Information (Details) Details 24 false false R25.htm 100300 - Disclosure - Organization and Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Potentially Dilutive Securities Excluded from Diluted Net Loss Per (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfOutstandingSharesOfPotentiallyDilutiveSecuritiesExcludedFromDiluted Organization and Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Potentially Dilutive Securities Excluded from Diluted Net Loss Per (Details) Details 25 false false R26.htm 100310 - Disclosure - Fair Value Measurement - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurement - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 26 false false R27.htm 100320 - Disclosure - Fair Value Measurement - Contractual Maturities of Available for Sale Securities (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementContractualMaturitiesOfAvailableForSaleSecuritiesDetails Fair Value Measurement - Contractual Maturities of Available for Sale Securities (Details) Details 27 false false R28.htm 100330 - Disclosure - Fair Value Measurement - Additional Information (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureFairValueMeasurementAdditionalInformationDetails Fair Value Measurement - Additional Information (Details) Details 28 false false R29.htm 100340 - Disclosure - Consolidated Balance Sheet Components - Schedule OF Property Plant And Equipment (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentDetails Consolidated Balance Sheet Components - Schedule OF Property Plant And Equipment (Details) Details 29 false false R30.htm 100350 - Disclosure - Consolidated Balance Sheet Components (Additional Information) (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsAdditionalInformationDetails Consolidated Balance Sheet Components (Additional Information) (Details) Details http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables 30 false false R31.htm 100360 - Disclosure - Consolidated Balance Sheet Components - Schedule Of Accrued Liabilities (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails Consolidated Balance Sheet Components - Schedule Of Accrued Liabilities (Details) Details 31 false false R32.htm 100370 - Disclosure - Convertible Preferred Stock and Stockholders Equity (Deficit) - Additional Information (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityDeficitAdditionalInformationDetails Convertible Preferred Stock and Stockholders Equity (Deficit) - Additional Information (Details) Details http://landosbiopharma.com/20221231/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityDeficit 32 false false R33.htm 100380 - Disclosure - Stock-based compensation - Additional information (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails Stock-based compensation - Additional information (Details) Details 33 false false R34.htm 100390 - Disclosure - Stock-based compensation - Summary of Stock Option Activity (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails Stock-based compensation - Summary of Stock Option Activity (Details) Details 34 false false R35.htm 100400 - Disclosure - Stock-based compensation - Calculation of Fair Value of Stock Option Grant Under ESPP Using Black-Scholes Option-Pricing Model (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensationCalculationOfFairValueOfStockOptionGrantUnderEsppUsingBlackscholesOptionpricingModelDetails Stock-based compensation - Calculation of Fair Value of Stock Option Grant Under ESPP Using Black-Scholes Option-Pricing Model (Details) Details 35 false false R36.htm 100410 - Disclosure - Stock-based compensation - Summary of Stock-Based Compensation Expenses (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpensesDetails Stock-based compensation - Summary of Stock-Based Compensation Expenses (Details) Details 36 false false R37.htm 100460 - Disclosure - Commitments and Contingencies (Additional Information) (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies (Additional Information) (Details) Details http://landosbiopharma.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies 37 false false R38.htm 100470 - Disclosure - License Agreement - Additional Information (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureLicenseAgreementAdditionalInformationDetails License Agreement - Additional Information (Details) Details 38 false false R39.htm 100480 - Disclosure - Income Taxes - Schedule Of Reconciliation Of The statutory federal Rate And The Company's Effective Tax Rate (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfTheStatutoryFederalRateAndTheCompanysEffectiveTaxRateDetails Income Taxes - Schedule Of Reconciliation Of The statutory federal Rate And The Company's Effective Tax Rate (Details) Details 39 false false R40.htm 100490 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredIncomeTaxAssetsAndLiabilitiesDetails Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details) Details 40 false false R41.htm 100500 - Disclosure - Income Taxes - Schedule Of Unrecognized Tax Benefits (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails Income Taxes - Schedule Of Unrecognized Tax Benefits (Details) Details 41 false false R42.htm 100510 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 42 false false R43.htm 100520 - Disclosure - Selected Quarterly Financial Data (unaudited) - Summary of Selected Quarterly Financial Data (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataUnauditedSummaryOfSelectedQuarterlyFinancialDataDetails Selected Quarterly Financial Data (unaudited) - Summary of Selected Quarterly Financial Data (Details) Details 43 false false R44.htm 100530 - Disclosure - Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) Details 44 false false R45.htm 100540 - Disclosure - Net Loss Per Common Share - Schedule of Outstanding Shares of Potentially Dilutive Securities Excluded from Diluted Net Loss Per Common Share (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfOutstandingSharesOfPotentiallyDilutiveSecuritiesExcludedFromDilutedNetLossPerCommonShareDetails Net Loss Per Common Share - Schedule of Outstanding Shares of Potentially Dilutive Securities Excluded from Diluted Net Loss Per Common Share (Details) Details 45 false false R46.htm 100550 - Disclosure - Subsequent Events (Additional Information) (Details) Sheet http://landosbiopharma.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events (Additional Information) (Details) Details http://landosbiopharma.com/20221231/taxonomy/role/DisclosureSubsequentEvents 46 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, us-gaap:PropertyPlantAndEquipmentUsefulLife - labp-20221231.htm 8 labp-20221231.htm labp-20221231.xsd labp-20221231_cal.xml labp-20221231_def.xml labp-20221231_lab.xml labp-20221231_pre.xml labp-ex10_15.htm labp-ex10_16.htm labp-ex10_17.htm labp-ex10_19.htm labp-ex23_1.htm labp-ex31_1.htm labp-ex32_1.htm img110863431_0.jpg img110863431_1.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true